Cell Therapy Manufacturing: A Medicine Maker’s “Dream”

May 25, 2026

Why CTMC CEO Jason Bock relishes the challenge of solving cell therapy’s most complex manufacturing and delivery problems

Read the full article here: The Medicine Maker

How is the increasing complexity of modalities reshaping CDMO differentiation and specialization strategies?

May 27, 2026

Read the full article here: Pharma's Almanac

May 7, 2026

When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from...

May 5, 2026

The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the...

Back